Atara Biotherapeutics's total assets for Q1 2025 were $62.04M, a decrease of -43.14% from the previous quarter. ATRA total liabilities were $117.11M for the fiscal quarter, a -43.26% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.